The introduction of this medication in Oz is sparking significant interest within the healthcare community. This novel dual medication – affecting both GLP-1 and GIP targets – presents a remarkably effective option https://ezmarkbookmarks.com/story22167434/new-retatrutide-australia-the-fresh-hope-for-weight-control